鼻腔鼻竇畸胎癌肉瘤的調(diào)強(qiáng)放射治療.ppt_第1頁(yè)
鼻腔鼻竇畸胎癌肉瘤的調(diào)強(qiáng)放射治療.ppt_第2頁(yè)
鼻腔鼻竇畸胎癌肉瘤的調(diào)強(qiáng)放射治療.ppt_第3頁(yè)
鼻腔鼻竇畸胎癌肉瘤的調(diào)強(qiáng)放射治療.ppt_第4頁(yè)
鼻腔鼻竇畸胎癌肉瘤的調(diào)強(qiáng)放射治療.ppt_第5頁(yè)
已閱讀5頁(yè),還剩23頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

Introduction Case Discussion,case,discussion,introduction,SNTCS,sino nasal terato carcino sarcoma, 80 cases reported,case,discussion,introduction,History,Vencent J. Hyams Director of the Otolaryngic Pathology branch of the Armed Forces Institute of Pathology,1968-1984,Teratoid carcinosarcoma ? Mixed mesodermal tumour ? Malignant teratoma and blastomas ?,1984,case,discussion,introduction,Characteristics,T1-weighted MR reveals a soft tissue filling the left ethmoid sinus, as uniformly high signal (*), and effusion (white arrowhead) in the left sphenoid sinus. Takasaki, K.,2006,Epithelial glandular carcinoma (at right) and osteosarcoma component (at left). (hematoxylin-eosin, original magnification x40). Smith, S. L.,2008,Endoscopic examination showing a left sinonasal tumor in the left middle turbinate. M, middle turbinate; S, nasal septum. Su, Y. Y., 2010,Treatment,case,discussion,introduction,Patients generally present with locally advanced-stage disease the highly malignant, aggressive biological behavior the presence of air filled paranasal spaces permits silent growth Distant metastasis of SNTCS is unusual and the most common cause of treatment failure is local recurrence Surgical excision and postoperative radiotherapy has become the most widely accepted therapeutic plan,Introduction Case Discussion,HPI,introduction,discussion,case,42-year-old man Two weeks history of progressive left nasal obstruction and intermittent nasal bleeding Nasal examination showed a moderately firm, reddish-purple mass in the left meatus Biopsy of the tumor revealed a heterogeneous admixture of epithelial and mesenchymal elements, suggesting SNTCS,Teratocarcinosarcoma Teratocarcinosarcoma consists of two components, epithelial and mesenchymal (hematoxylin-eosin, original magnification 200),cT3N0M0,MRI,introduction,discussion,case,MRI revealed a soft tissue filling the left meatus, maxillary and ethmoid sinus, and effusion in the left maxillary sinus,introduction,discussion,case,Anterior craniofacial resection IMRT GTV included the residual gross disease in the nasal cavity and paranasal sinus CTV-60 includes the GTV with a 510 mm margin, the whole nasal cavity and the involved paranasal sinus CTV-54 high-risk local structures (including the whole nasopharynx, lower half of sphenoid sinus, et al) lymphatic regions (including ipsilateral lymph node levels IB, II, III and VA) A 3-mm margin was added to produce PTVs PTV-66 was prescribed to 66 Gy with 2.2 Gy/fraction PTV-60 was prescribed to 60 Gy with 2.0 Gy/fraction PTV-54 was prescribed to 54 Gy with 1.8 Gy/fraction,Treatment,Follow-up,introduction,discussion,case,Now 3.5 years have passed since the irradiation therapy No severe dry-eye syndrome, and other severe radiation-induced ocular toxicities happened No evidence of recurrence or metastasis,Introduction Case Discussion,Shoulders ?,introduction,case,discussion,Sinonasal tumors,Frontal Sinus Maxillary Sinus Ethmoid Sinus Spenoid Sinus,1,2,3,4,Challenge !,introduction,case,discussion,IMRT,introduction,case,discussion,3-beam conventional 2D,6-beam conventional 3D conformal,7-beam IMRT,A dosimetry comparison between (a) a 3-beam conventional 2D treatment, (b) a 6-beam conventional 3D conformal RT treatment, and (c) a 7-beam IMRT treatment. The PTV is represented by the solid red line. The 100% and 70% of the prescription dose are shown by the green and red colour-washed areas. A better dose conformity to the PTV can be achieved in the IMRT treatment.,Ghent Experience,introduction,case,discussion,2009,Madani, I., 2009,Dosevolume Constraints,introduction,case,discussion,Madani, I., 2009,Visual Pathway Dose,introduction,case,discussion,Madani, I., 2009,Acute Toxicity,introduction,case,discussion,Madani, I., 2009,Studies Reported,introduction,case,discussion,Madani, I., 2009,CTV Delineation,introduction,case,discussion,Implementation Strategy,2001,introduction,case,discussion,Claus, F.,2001,introduction,case,discussion,“Compartment-related CTV Definition”,In those regions where GTV was flanked by intact bone, no margin was added In those regions where GTV invaded compartments enclosed by bone, like other paranasal sinuses, or extended up to their ostia, the whole compartment was included in the CTV contours In those regions where GTV invaded radiologically defined spaces known to resist poorly invasion by malignant tumors (e.g., masticator or parapharyngeal spaces), the entire space was added,Claus, F.,2001,Cervical Lymph Nodes,Duthoy, W.,2005,introduction,case,discussion,2005,LN Recurrence,Duthoy, W.,2005,introduction,case,discussion,2006,introduction,case,discussion,CTV Delineation cont,CTV Delineation cont,“ Indeed, in absence of unambiguous information on the surgical procedure and comprehensive report of the pathological analysis, a too selective selection and delineation of the CTV may lead to an unacceptable high rate of loco-regional recurrences ”,Vincent Gregoire, 2006,It will not be inappropriate to be generous in target volume delineation,introducti

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論